MAOB and schizophrenia: Study results of 302 Caucasian male and female schizophrenia patients aged 18–62 suggests that some catechol-O-methyltransferase (COMT) and monoamine oxidase B (MAO-B) genetic variants are associated with a sex-specific increase in the severity of negative symptoms [50].